in cooperation with The Czech Leukemia Study Group fo for The Austrian Collaborative Study Group on

Alemtuzumab in chronic lymphocytic leukaemia, other lymphoproliferative disease and autoimmune disorders

R. Greil, M. Fiegl, G. Gastl, 2008 .

Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients

R. Greil, M. Steurer, M. Fiegl, 2014, Annals of Hematology.

Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients

R. Greil, M. Steurer, M. Fiegl, 2011, Annals of Hematology.